Advancements and challenges in CAR T cell therapy in autoimmune diseases
Georg Schett(Karolinska University Hospital), Dimitrios Mougiakakos(Otto-von-Guericke-Universität Magdeburg), Aiden Haghikia(Friedrich-Alexander-Universität Erlangen-Nürnberg), Fabian Müller(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jule Taubmann(Universitätsklinikum Erlangen), Roberto Caricchio(University of Massachusetts Chan Medical School), Andréas Mackensen(University Medical Center Freiburg), Maria Antonietta D’Agostino(Agostino Gemelli University Polyclinic), Wei Wang(Tongji Hospital), Peter A. Merkel(University of Pennsylvania), Ralf Gold(St. Josef-Hospital), Carl H. June(University of Pennsylvania), R. Furie(Northwell Health), Franco Locatelli(Bambino Gesù Children's Hospital)
Cited by 203
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
|Immunity|2015|919
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|737
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708